Patrick Campbell

Very excited to share something that has been in the works for several years now, and is finally ready for prime time. Moving the Needle in Medicine - a new monthtly podcast from @HCPLiveCardio focused on the people and decisions that are actually changing how medicine is practiced. Couldn’t be more thrilled to kick off our inaugural episode with my colleague, mentor, friend and someone that motivates me to be better single every day: @DrMarthaGulati. We discuss her amazing journey, the evolution of women’s cardiovascular health, spanning early career inflection points to national guideline leadership to building multiple women’s health centers across the nation. Episode one is now live—go check it out!!! open.spotify.com/episode/2CUOkV…

Heading to Denver for #AAD2026 tmmw—if anyone needs me, I'll be the one joining the airport lines with half the dermatology world. ✈️ Kicking off at the @SkinOfColor (SOCS) Scientific Symposium, then covering late-breaking data and interviews for @HCPLiveNews. Stay tuned! 👋

Only 7% of Americans meet all five healthy lifestyle recommendations. Cognitive scientist and former NFL Pro Bowler Julius Thomas, Psy.D., explains why that gap is fueling chronic disease — and what it actually takes to protect yourself. #Prevention #ChronicDisease #MentalHealth #Longevity #HealthyLifestyle #StressManagement #Inflammation Watch our interview now: hubs.li/Q047jzdd0

DELL REWARD ACCOUNTS RECEIVING $25 Most of us have lots of dell reward accounts from past deals. Worth checking your emails (ymmv)

In this episode of The Expert APProach host Joy Maulik, CRNP, sits down with LUGPA leadership Celeste Kirschner, CAE, MHSA, and Scott Sellinger, MD, FACS, to explore leadership, advocacy, workforce evolution, and the future of independent urology. @UrologyUS urologytimes.com/view/the-exper…

Novo Nordisk will lower the US list price of Wegovy, Ozempic and Rybelsus to $675/month starting in 2027. What does that mean for patients? #Wegovy #Ozempic #Rybelsus #Semaglutide #ObesityCare #DiabetesCare #HealthcareAccess Learn more: hubs.li/Q044qsp50

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, (@AmyPearlman1) sits down with Alan J. Wein, MD, PhD (hon), FACS, to discuss how the field of urology has evolved and how clinicians can thoughtfully evolve alongside it. Watch here: urologytimes.com/view/pearls-pe…

WATCH🎥: Kristen Scarpato, MD, MPH, (@Scarps_kristen) reflects on a #SWIU2026 panel discussion on imposter syndrome. @VUMCurology @SWIUorg urologytimes.com/view/kristen-s…

We cannot wait to welcome you to Galveston island in November 🏝️ ☀️ 🌊! You definitely don’t want to miss this inaugural clinical trials summit!!

RT @OncLive: CAR T-cell therapy, leading hematologists like @szusmani @MSKCancerCenter and @abhinav_deol @karmanoscancer and... puppies! 🐶…

Simultaneous or rapid initiation of #QuadTherapy for #HFrEF The case gets stronger & stronger w/ each passing year. INITIATE-HFrEF study now in @JACCJournals @gcfmd @JavedButler1 @DCRINews #DontDelay jamanetwork.com/journals/jamac… jacc.org/doi/10.1016/j.…

TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198 - The Lancet thelancet.com/journals/lance…

🎉 Congrats to @UHhospitals @IrinaJaeger on @UrologyTimes cover feature! Sharing expert insights on HoLEP patient selection & technique. urologytimes.com/view/inside-ho… #HoLEP #UrologyInnovation #UIproud

An important episode of #kidneycompass We discuss: - Racial variations in incidence & natural history of IgAN - The first reported phase 3 GFR data from an APRIL/BAFF inhibitor (telitacicept) in IgAN - An interesting piece of nephrological history… @SWadhwaniMD

In a recent @HCPLiveNews article, Dr. John Gill, MD, shared insights into data from our Phase 2 BESTOW trial and the potential of our investigational anti-CD40L antibody tegoprubart to address the unmet needs of #transplant patients: hcplive.com/view/innovatio… $ELDN

!!! Retatrutide coming in hot with some serious weight loss numbers this AM. Story later on @HCPLiveNews:

Positions filled and match rates for the 2025 NRMP Medicine and Pediatric Specialties Fellowship Match

Grateful for assigned Discussant role for #AHA25 Late-Breaking Science on Sun Nov 8 — DAPA ACT HF-TIMI 68 BP & SOTA-P-CARDIA. Fresh data, practical takeaways, and what we do next. Bring your questions and join the dialogue.

Come join us for the @FloridaACC Journal Club! 🔔 🗓 Oct 9 | 🕕 6–7 PM ET Discussing 3 landmark ESC ASM 2025 trials with: 👨‍🏫 Moderator: Robby Wu, DO, FACC (USF) 🫀 DIGIT-HF: Leonardo A. Almaguer Gongora, MD – HCA Aventura 💓 MAPLE-HCM: Nguyen Nguyen, MD – NCH Rooney Heart Institute ❤️ REBOOT-CNIC: Kinley Buckley, DO – USF Register 👉 accfl.org/event-6367985 #CardioTwitter #ACCFIT #FIT #MedEd @ACCinTouch @rzw113 @XavierPrida @dkenigsberg @CarlosVergaraMD @JustinMarkMD @SephienMD @RheaSancassani @russcolombomd

🔥 New in @NatureMedicine How do you communicate lifetime benefits expected with HFpEF therapies? New data from 3 RCTs (#DELIVER #FINEARTS #PARAGON) estimate up to *5 years* of event-free survival w combination Rx #GDMT for HFpEF has finally arrived! 🔗nature.com/articles/s4159…